Literature DB >> 8607838

Molecular cloning, cDNA structure, and chromosomal localization of the human type II cGMP-dependent protein kinase.

S Orstavik1, R Solberg, K Taskén, M Nordahl, M R Altherr, V Hansson, T Jahnsen, M Sandberg.   

Abstract

The type II cGMP-dependent protein kinase is an enzyme originally isolated from the small intestine, and is thought to be involved in the regulation of intestinal ion transport and fluid secretion. A complementary DNA clone encoding a part of the human type II cGMP-dependent protein kinase was isolated from a cerebellum library. Based on sequence information from this complementary DNA, the 5'-end of the type II cGMP-dependent protein kinase was amplified from human brain messenger RNA using polymerase chain reaction. The composite complementary DNA encoded a 762 amino acid protein with a calculated molecular mass of 87.4 kDa. Messenger RNAs encoding the type II cGMP-dependent protein kinase were detected in small intestine, colon and prostate. By using polymerase chain reaction and Southern blotting on somatic cell hybrids, the gene encoding, the type II cGMP-dependent protein kinase was mapped to human chromosome 4q13.1-q21.1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8607838     DOI: 10.1006/bbrc.1996.0477

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Nitric oxide-cyclic GMP signaling in stem cell differentiation.

Authors:  Kalpana Mujoo; Joshua S Krumenacker; Ferid Murad
Journal:  Free Radic Biol Med       Date:  2011-10-06       Impact factor: 7.376

2.  Nitric oxide/cyclic guanosine monophosphate inducers sodium nitroprusside and L-arginine inhibit the proliferation of gastric cancer cells via the activation of type II cyclic guanosine monophosphate-dependent protein kinase.

Authors:  Xiaoyuan Yao; Yan Wu; Miaolin Zhu; Hai Qian; Yongchang Chen
Journal:  Oncol Lett       Date:  2015-05-19       Impact factor: 2.967

3.  Cyclic GMP-dependent protein kinase II is necessary for macrophage M1 polarization and phagocytosis via toll-like receptor 2.

Authors:  Wei-Ting Liao; Huey-Ling You; Changgui Li; Jan-Gowth Chang; Shun-Jen Chang; Chung-Jen Chen
Journal:  J Mol Med (Berl)       Date:  2014-12-06       Impact factor: 4.599

4.  A novel gain-of-function mutant of the cyclic GMP-dependent protein kinase egl-4 affects multiple physiological processes in Caenorhabditis elegans.

Authors:  David M Raizen; Kevin M Cullison; Allan I Pack; Meera V Sundaram
Journal:  Genetics       Date:  2006-03-17       Impact factor: 4.562

Review 5.  Cyclic nucleotide selectivity of protein kinase G isozymes.

Authors:  Choel Kim; Rajesh Sharma
Journal:  Protein Sci       Date:  2020-12-10       Impact factor: 6.993

6.  A 26-Year-Old Female with Systemic Mastocytosis with Associated Myeloid Neoplasm with Eosinophilia and Abnormalities of PDGFRB, t(4;5)(q21;q33).

Authors:  Laura E Brown; Da Zhang; Diane L Persons; Abdulraheem Yacoub; Shivani Ponnala; Wei Cui
Journal:  Case Rep Hematol       Date:  2016-08-25

7.  PRKG2 Splice Site Variant in Dogo Argentino Dogs with Disproportionate Dwarfism.

Authors:  Gabriela Rudd Garces; Maria Elena Turba; Myriam Muracchini; Alessia Diana; Vidhya Jagannathan; Fabio Gentilini; Tosso Leeb
Journal:  Genes (Basel)       Date:  2021-09-24       Impact factor: 4.096

8.  Expression of cGMP-dependent protein kinase, PKGIα, PKGIβ, and PKGII in malignant and benign breast tumors.

Authors:  Fatemeh Karami-Tehrani; Faranak Fallahian; Morteza Atri
Journal:  Tumour Biol       Date:  2012-07-13

9.  PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells.

Authors:  Lu Jiang; Ting Lan; Yongchang Chen; Jianrong Sang; Yueying Li; Min Wu; Yan Tao; Ying Wang; Hai Qian; Luo Gu
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

10.  Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells.

Authors:  Min Wu; Yongchang Chen; Lu Jiang; Yueying Li; Ting Lan; Ying Wang; Hai Qian
Journal:  Oncol Lett       Date:  2013-10-15       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.